The Dementia Discovery Fund (DDF), the venture capital fund investing in, and creating, biotech companies pursuing transformational therapeutic approaches for dementias, has announced the appointments of Dr Lynne Hughes and Dr James Summers as Venture Partners, bringing additional expertise in neuroscience research and development.
Dr Jonathan Behr, Partner at The Dementia Discovery Fund, said: “We are delighted to welcome Lynne and Jim to DDF. Both are world-recognised experts in dementia and neuroscience R&D and their considerable expertise reinforces the key differentiation and value proposition of the DDF as we continue to invest in innovative dementia therapeutics and platform companies. Their contribution is expected to be particularly valuable as our portfolio companies mature and advance into clinical-stage development.”
Dr Hughes, said: “I am delighted to join DDF and its experienced team. The firm has been a pioneer in neuroscience investing, funding innovative dementia research and working creatively with entrepreneurs, academics and the industry to design and develop global Alzheimer’s disease trials. I look forward to working with my colleagues to help manage and expedite drug development to combat this dreadful disease.”
Dr Summers, said: “I am pleased to join the impressive DDF team and excited to work together with them to achieve the important goal of bringing transformative therapies to patients with dementia.”
Image credit: Micheile Henderson